2 results
Approved WMOPending
To evaluate the efficacy and safety of nilotinib in spondyloarthritis
Approved WMORecruiting
The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary…